India okays GSK, Sanofi COVID-19 vaccine trials
Indian health authorities approved on Thursday the start of the late-stage clinical trial of the COVID-19 vaccine developed by Sanofi S.A. and GlaxoSmithKline plc.
The two companies confirmed they ar…
- Russia reports 24,818 new COVID cases, 734 deaths
- Europe extends losses as Delta variant prompts new concerns
